Pages that link to "Q39699300"
Jump to navigation
Jump to search
The following pages link to mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs (Q39699300):
Displaying 50 items.
- PHLPP-Mediated Dephosphorylation of S6K1 Inhibits Protein Translation and Cell Growth (Q24292938) (← links)
- mTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptide (Q24305343) (← links)
- Impairment of cytoplasmic eIF6 activity restricts lymphomagenesis and tumor progression without affecting normal growth (Q24306324) (← links)
- Control of Paip1-eukayrotic translation initiation factor 3 interaction by amino acids through S6 kinase (Q24317685) (← links)
- Translational homeostasis via the mRNA cap-binding protein, eIF4E (Q24320659) (← links)
- Proteomic analysis of cap-dependent translation identifies LARP1 as a key regulator of 5'TOP mRNA translation (Q24337405) (← links)
- A novel 4EHP-GIGYF2 translational repressor complex is essential for mammalian development (Q24339443) (← links)
- Largen: a molecular regulator of mammalian cell size control (Q24339473) (← links)
- Regulation of TOR by small GTPases (Q24598385) (← links)
- Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator (Q24609227) (← links)
- Spatial regulation of the mTORC1 system in amino acids sensing pathway (Q24612853) (← links)
- An emerging role for TOR signaling in mammalian tissue and stem cell physiology (Q24629305) (← links)
- mTOR: from growth signal integration to cancer, diabetes and ageing (Q24633662) (← links)
- mTOR signaling in growth control and disease (Q24634174) (← links)
- Regulation of global and specific mRNA translation by the mTOR signaling pathway (Q26771382) (← links)
- Signalling to eIF4E in cancer (Q26777735) (← links)
- Amino acid management in cancer (Q26798087) (← links)
- Ribosome profiling: a Hi-Def monitor for protein synthesis at the genome-wide scale (Q26822785) (← links)
- mTOR Signaling in Protein Translation Regulation: Implications in Cancer Genesis and Therapeutic Interventions (Q27007511) (← links)
- Dietary flavonoid fisetin: a novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management (Q27026839) (← links)
- The expanding role of mTOR in cancer cell growth and proliferation (Q27027797) (← links)
- Arl2-GTP and Arl3-GTP regulate a GDI-like transport system for farnesylated cargo (Q27675096) (← links)
- The Selective Class I PI3K Inhibitor CH5132799 Targets Human Cancers Harboring Oncogenic PIK3CA Mutations (Q27851644) (← links)
- Judicious Toggling of mTOR Activity to Combat Insulin Resistance and Cancer: Current Evidence and Perspectives (Q28071388) (← links)
- mTOR inhibitors in cancer therapy (Q28079129) (← links)
- The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation (Q28291406) (← links)
- S6K1 and 4E-BP1 are independent regulated and control cellular growth in bladder cancer (Q28477972) (← links)
- Phosphoproteomic Profiling of In Vivo Signaling in Liver by the Mammalian Target of Rapamycin Complex 1 (mTORC1) (Q28478869) (← links)
- Metformin Antagonizes Cancer Cell Proliferation by Suppressing Mitochondrial-Dependent Biosynthesis (Q28551227) (← links)
- eIF6 coordinates insulin sensitivity and lipid metabolism by coupling translation to transcription (Q28586333) (← links)
- Metabolic control by S6 kinases depends on dietary lipids (Q28731457) (← links)
- Regulation of the mTOR Complex 1 Pathway by Nutrients, Growth Factors, and Stress (Q29614493) (← links)
- The functions and regulation of the PTEN tumour suppressor (Q29615536) (← links)
- mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway (Q30425628) (← links)
- Glucose-TOR signalling reprograms the transcriptome and activates meristems (Q33355557) (← links)
- The role of target of rapamycin signaling networks in plant growth and metabolism (Q33357441) (← links)
- A Phase I Study of Cixutumumab (IMC-A12) in Combination with Temsirolimus (CCI-779) in Children with Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Report (Q33419115) (← links)
- Oxygen sufficiency controls TOP mRNA translation via the TSC-Rheb-mTOR pathway in a 4E-BP-independent manner. (Q33668452) (← links)
- The mTOR inhibitor rapamycin synergizes with a fatty acid synthase inhibitor to induce cytotoxicity in ER/HER2-positive breast cancer cells (Q33670472) (← links)
- Regulation of CHK1 by mTOR contributes to the evasion of DNA damage barrier of cancer cells (Q33685874) (← links)
- Effectiveness and molecular interactions of the clinically active mTORC1 inhibitor everolimus in combination with tamoxifen or letrozole in vitro and in vivo (Q33739267) (← links)
- mTORC1 and JNK coordinate phosphorylation of the p70S6K1 autoinhibitory domain in skeletal muscle following functional overloading (Q33764652) (← links)
- Chronic mTOR activation promotes cell survival in Merkel cell carcinoma (Q33841361) (← links)
- Retracted: Simultaneous Inhibition of mTOR-Containing Complex 1 (mTORC1) and MNK Induces Apoptosis of Cutaneous T-Cell Lymphoma (CTCL) Cells (Q34031521) (← links)
- Suppression of Cellular Transformation by Poly (A) Binding Protein Interacting Protein 2 (Paip2) (Q34034773) (← links)
- Developments in Burkitt's lymphoma: novel cooperations in oncogenic MYC signaling (Q34039568) (← links)
- Mnk earmarks eIF4E for cancer therapy (Q34069446) (← links)
- Targeting mTOR dependency in pancreatic cancer (Q34092334) (← links)
- The cancerous translation apparatus (Q34182649) (← links)
- A critical role for mTORC1 in erythropoiesis and anemia (Q34263944) (← links)